Drug Shortage Report for HUMALOG

Last updated on 2024-04-13 History
Report ID 223890
Drug Identification Number 02229704
Brand name HUMALOG
Common or Proper name insulin lispro injection
Company Name ELI LILLY CANADA INC
Market Status MARKETED
Active Ingredient(s) INSULIN LISPRO
Strength(s) 100UNIT
Dosage form(s) SOLUTION
Route of administration SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR
Packaging size Carton package containing one 10 mL vial
ATC code A10AB
ATC description INSULINS AND ANALOGUES
Reason for shortage Delay in shipping of the drug.
Anticipated start date 2024-04-01
Actual start date 2024-04-01
Estimated end date 2024-04-12
Actual end date 2024-04-12
Shortage status Resolved
Updated date 2024-04-13
Company comments The estimated end date represents projected availability at the main Lilly warehouse. For any questions or concerns, please contact our Customer Response Centre at 1-888-545-5972 (Monday-Friday, 9 a.m. to 5 p.m. Eastern Time, excluding holidays).
Health Canada comments
Tier 3 Status No
Contact Address EXCHANGE TOWER, 130 KING STREET WEST
TORONTO, ONTARIO
CANADA M5X 1B1
Company contact information Lilly Canada’s Customer Response Centre 1-888-545-5972.

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v9 2024-04-13 English Compare
v8 2024-04-12 French Compare
v7 2024-04-12 English Compare
v6 2024-04-02 English Compare
v5 2024-04-01 French Compare
v4 2024-04-01 English Compare
v3 2024-03-28 French Compare
v2 2024-03-28 English Compare
v1 2024-03-28 English Compare

Showing 1 to 9 of 9